| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |